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CORRESPONDENCE
Scleromyxedema diagnosis following 
unexplained encephalopathy
Scleromyxedema is a rare idiopathic disorder, character-
ized by papules in a thickened mucinous dermis, with fi bro-
blastic proliferation and monoclonal paraproteinemia [1, 
2]. Typically, scleromyxedema affects middle-aged men, 
has a chronic progressive course and frequently pre sents 
extracutaneous complications that generally occur after 
cutaneous disease [3].
A 67-year-old man, previously healthy, presented with 
vertigo, nausea and gait unsteadiness. Examination dis-
closed slow right phase rotatory nystagmus, without 
ataxia. Diagnosed with a positional benign vertigo, he 
was discharged with symptomatic medication. Three days 
later he suddenly lost consciousness from which he did not 
recover. At admission he was in a coma, with conjugate 
ocular movements and decerebrating posture with noxious 
stimuli, without fever or meningeal signs. MRI was normal 
and laboratory studies unremarkable. A few hours later he 
had a tonic-clonic generalized seizure. EEG showed slow 
and irregular background activity. CSF evidenced pleocy-
tosis (1800 cells, 95% neutrophils), with normal protein 
and glucose contents, and negative microbiologic, viro-
logic and serologic studies. He was prescribed valproate, 
cefotaxime, ampicillin, acyclovir and dexamethasone. He 
started to recover (d3), awake but with incomprehensible 
speech, very confused and agitated, without motor defi cits; 
he had two more generalized seizures. LP was repeated 
(d7), and was completely normal. The patient slowly im-
proved and, at day 11, he could speak and comprehend 
normally, but then started complex visual hallucinations: 
a two hectares fi eld in the wall, smoke, and animals run-
ning. This improved spontaneously, with no complaints on 
dismissal (d14).
Six months later he presented a widespread symmetric 
eruption of 2-3 mm, fi rm, waxy, closely spaced pa pules 
predominating in the hands, forearms and forehead 
 (fi gure 1). Physical examination also revealed diffuse er-
ythema and induration of the skin, leading to decreased 
motility of the mouth and joints, especially the hands. Skin 
biopsy showed a diffuse mucin deposit in the dermis and 
marked fi broblastic proliferation. The most relevant results 
of the hematological investigation were IgG monoclonal 
gammopathy with λ light chains and absence of thyroid 
disease.
Several well-described CNS manifestations in sclero-
myxedema are encephalopathy, psychosis, stroke-like 
syndromes, seizures and, rarely, vertigo, memory loss, 
gait disturbance and dysarthria [3]. Also scleroderma-like 
lesions and Parkinson’s disease have been described as 
possibly linked with exposure to pesticides [4]. There are 
reports of a specifi c “dermato-neuro” syndrome, in which 
fever, disturbed consciousness and seizures follow a ﬂ u-
like illness [5]. CNS symptoms usually appear in patients 
with previous cutaneous disease concurring with exacer-
bations of the later [3]. There are six reports describing 
neurological symptoms preceding cutaneous disease, in 
periods ranging from days till two years, with the follo-
wing presentations: stroke-like syndrome, encephalopathy 
and encephalitis. In all patients neurological investigations 
were normal, except for EEG (slow diffuse background 
activity) and, occasionally, elevated CSF protein [3].
The mechanism by which the CNS is affected in sclero-
myxedema is unknown, but paraproteinemia and mucin 
cerebral deposition have been postulated [6]. These mech-
anisms, however, lack validity, some patients having no 
paraproteinemia with a negative brain biopsy [6]. An im-
munological abnormal response was recently document-
ed, with increased interleukin 6 production and abnormal 
blood-brain barrier function [6].
Figure 1. Firm, waxy, closely spaced papules particularly 
visible in the forehead A), but also in the forearms B).
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Our patient had a vertigo syndrome followed shortly by 
comatose state, seizures, CSF pleocytosis and, in the re-
covery phase, hallucinations. This case, on neurological 
grounds, remained a puzzle until the detection of cutane-
ous lesions. Although it is not possible to defi nitely link 
these two fi ndings, previous reports and the absence of any 
other known neurological disorder which could account 
for such a presentation, after exhaustive investigation and 
proper follow-up, strongly suggest that they are caused by 
the same systemic condition, that is, scleromyxedema. Af-
ter this, proper treatment and anticipation of other extra-
cutaneous complications was undertaken. 
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Linear atrophoderma of Moulin
A 42-year-old Caucasian woman presented a 5-year his-
tory of atrophic brown maculae on the left arm and trunk 
with an asymmetrical linear distribution forming an in-
verted U-shape from the breast area up the upper arm, an 
S-shape on the anterior abdomen, a V-shape on the back 
toward the median line (fi gure 1). The patient reported 
that the lesions developed few days after working under 
sun exposure in contact with parasiticide substances and 
tomato plants. There was no history of atopic dermati-
tis, psoriasis, or previous dermatitis. Past medical history 
was unremarkable. She denied any past treatment of the 
lesions. A biopsy revealed hyperpigmentation of epider-
mal basal cells, slight thickening of the collagen fi bers in 
the mid-deep dermis with a rare perivascular lymphocytic 
infi ltrate (fi gure 1). Laboratory fi ndings were unremark-
able except for an increase of hepatic enzymes compatible 
with hepatic steatosis. Antinuclear (ANA) and anti-DNA 
antibodies were negative and immunoglobulins were sug-
gestive of previous common viral exanthematic diseases. 
The clinical picture, the histology, along with the lack of 
autoantibodies, were compatible with Linear Atropho-
derma of Moulin (LAM) following Blaschko’s lines (BL). 
Cytogenetic analysis found a normal karyotype without 
genetic mosaicisms. Following treatment with a high dose 
of vitamin E (400 UI/d) and topical clobetasol propionate, 
a slight improvement of the lesions was observed.
Firstly described by Moulin et al. in 1992 in 5 patients 
[1], LAM is a distinct clinical entity characterized by 
acquired atrophic bandlike skin lesions that often show 
hyperpigmentation and always follow the lines of Blasch-
ko. No preceding inﬂ ammation is noted, but a transient 
inﬂ ammatory stage is perhaps often unrecognized, and 
there is no induration or scleroderma. Usually the con-
dition begins in childhood or adolescence, and there is 
no evidence of any long-term progression. Histopatho-
logically, an irregular moderate hyperpigmentation of the 
lower part of the epidermis is found, along with a few 
perivascular lymphocytes in the dermis and slight thick-
ening of the collagen bundles, as in our case [2]. The 
existence of LAM is controversial in its possible clini-
cal overlap with linear scleroderma or morphea. Never-
theless, this latter is characterized by one or more linear 
streaks of progressive induration that can extend through 
the dermis, subcutaneous tissue, and muscle to the un-
derlying bone, causing signifi cant deformities [3]. The 
lack of autoantibodies, such as ANA, found in 73% of 
adult patients with linear scleroderma and the chronic and 
unvaried course make this diagnosis unlikely in our pa-
tient, leading to the more compatible diagnosis of LAM 
[4]. The cause and pathogenesis of this disorder remain 
Figure 1. Asymmetrical S-shaped linear distribution on the 
left arm and trunk of the atrophic brown maculae. Histology 
of the skin biopsy characterized by the hyperpigmentation of 
epidermal basal cells and the slight thickening of the collagen 
fi bers of the mid-deep dermis (H & E, × 150).
jleejd00492_cor1.indd   79 12/10/2007   3:58:37 PM
d
o
i  :
 1
0.
16
84
/e
jd
.2
00
7.
03
16
